Company / Total Debt
Biogen Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$6.3B
FY2025
5-year range
$6.3B / $6.9B
FY2021-FY2025
Trend
-0.1%
vs FY2024
Sector context
#15 of 86
Health Care
What the data says
Biogen's total debt of $6.3B is higher than 83% of companies in the Health Care sector (FY2025). Total Debt has fluctuated over the past 10 years, ranging from $4.5B in FY2019 to $7.4B in FY2020.
Based on SEC 10-K filings.
$6.3B in FY2025 with a 5-year CAGR of -3.3%. Top quartile in the Health Care sector.
Improved from $6.9B to $6.3B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -3.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 86This company $6.3B Sector average $6.0B
▼
+5.6% above sector average
Key checks
Key Insights
- 5-year CAGR of -3.3%, indicating a declining trend.
- In FY2025, total debt decreased 0.1% year-over-year.
- Ranks #15 out of 86 companies in the Health Care sector.
- Peak total debt was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.3B | -0.1% |
| FY2024 | $6.3B | -9.3% |
| FY2023 | $6.9B | +10.5% |
| FY2022 | $6.3B | +0.1% |
| FY2021 | $6.3B | -15.5% |
| FY2020 | $7.4B | +66.5% |
| FY2019 | $4.5B | -24.9% |
| FY2018 | $5.9B | +0.0% |
| FY2017 | $5.9B | -8.9% |
| FY2016 | $6.5B | -0.1% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026